|
🐜
|
Ledipasvir and sofosbuvir for untreated HCV genotype 1 infection.
24 auth.
N. Afdhal,
S. Zeuzem,
P. Kwo,
M. Chojkier,
N. Gitlin,
M. Puoti,
M. Romero‐Gomez,
J. Zarski,
K. Agarwal,
P. Buggisch,
...
G. Foster,
N. Bräu,
M. Buti,
I. Jacobson,
G. Subramanian,
Xiao Ding,
H. Mo,
Jenny C. Yang,
P. Pang,
W. Symonds,
J. Mchutchison,
A. Muir,
A. Mangia,
P. Marcellin
|
10 |
2014 |
10
🐜
|
|
🐜
|
Sofosbuvir and Velpatasvir for HCV Genotype 2 and 3 Infection.
35 auth.
G. Foster,
N. Afdhal,
S. Roberts,
N. Bräu,
E. Gane,
S. Pianko,
E. Lawitz,
A. Thompson,
M. Shiffman,
C. Cooper,
W. Towner,
B. Conway,
P. Ruane,
M. Bourliere,
T. Asselah,
...
T. Berg,
S. Zeuzem,
W. Rosenberg,
K. Agarwal,
C. Stedman,
H. Mo,
H. Dvory‐Sobol,
Lingling Han,
Jing Wang,
J. McNally,
A. Osinusi,
D. Brainard,
J. Mchutchison,
F. Mazzotta,
T. Tran,
S. Gordon,
K. Patel,
N. Reau,
A. Mangia,
M. Sulkowski
|
9 |
2015 |
9
🐜
|
|
🐜
|
Tocilizumab in Hospitalized Patients with Severe Covid-19 Pneumonia
23 auth.
I. Rosas,
N. Bräu,
M. Waters,
Ronaldo C. Go,
B. Hunter,
S. Bhagani,
D. Skiest,
M. Aziz,
N. Cooper,
I. Douglas,
...
S. Savic,
T. Youngstein,
L. Del Sorbo,
Antonio Cubillo Gracian,
D. J. De La Zerda,
A. Ustianowski,
M. Bao,
S. Dimonaco,
E. Graham,
B. Matharu,
H. Spotswood,
L. Tsai,
A. Malhotra
|
9 |
2021 |
9
🐜
|
|
🐜
|
Ledipasvir and Sofosbuvir for HCV in Patients Coinfected with HIV-1.
28 auth.
S. Naggie,
C. Cooper,
M. Saag,
K. Workowski,
P. Ruane,
W. Towner,
K. Marks,
A. Luetkemeyer,
R. Baden,
P. Sax,
E. Gane,
Jorge Santana-Bagur,
L. Stamm,
Jenny C. Yang,
P. German,
...
H. Dvory‐Sobol,
Liyun Ni,
P. Pang,
J. Mchutchison,
C. Stedman,
J. Morales-Ramirez,
N. Bräu,
D. Jayaweera,
A. Colson,
P. Tebas,
D. Wong,
D. Dieterich,
M. Sulkowski
|
9 |
2015 |
9
🐜
|
|
🦁
|
Slower fibrosis progression in HIV/HCV-coinfected patients with successful HIV suppression using antiretroviral therapy.
7 auth.
N. Bräu,
M. Salvatore,
C. Ríos-Bedoya,
Alberto Fernández-Carbia,
F. Paronetto,
J. Rodríguez-Orengo,
...
M. Rodríguez-Torres
|
9 |
2006 |
9
🦁
|
|
🐜
|
Efficacy of 8 Weeks of Sofosbuvir, Velpatasvir, and Voxilaprevir in Patients With Chronic HCV Infection: 2 Phase 3 Randomized Trials.
30 auth.
Ira M. Jacobson,
E. Lawitz,
E. Gane,
B. Willems,
P. Ruane,
R. Nahass,
S. Borgia,
S. Shafran,
K. Workowski,
Brian L. Pearlman,
R. Hyland,
L. Stamm,
E. Svarovskaia,
H. Dvory‐Sobol,
Yanni Zhu,
...
G. Subramanian,
D. Brainard,
J. Mchutchison,
N. Bräu,
T. Berg,
K. Agarwal,
B. Bhandari,
Mitchell N. Davis,
J. Feld,
G. Dore,
C. Stedman,
A. Thompson,
T. Asselah,
S. Roberts,
G. Foster
|
8 |
2017 |
8
🐜
|
|
🐜
|
Glecaprevir and Pibrentasvir in Patients with HCV and Severe Renal Impairment
17 auth.
E. Gane,
E. Lawitz,
D. Pugatch,
G. Papatheodoridis,
N. Bräu,
A. Brown,
S. Pol,
V. Leroy,
M. Persico,
Christophe Moreno,
...
M. Colombo,
E. Yoshida,
D. Nelson,
Christine A. Collins,
Y. Lei,
M. Kosloski,
F. Mensa
|
8 |
2017 |
8
🐜
|
|
🐜
|
Care of patients coinfected with HIV and hepatitis C virus: 2007 updated recommendations from the HCV-HIV International Panel.
11 auth.
V. Soriano,
M. Puoti,
M. Sulkowski,
A. Cargnel,
Y. Benhamou,
M. Peters,
...
S. Mauss,
N. Bräu,
A. Hatzakis,
S. Pol,
J. Rockstroh
|
8 |
2007 |
8
🐜
|
|
🦁
|
Presentation and outcome of hepatocellular carcinoma in HIV-infected patients: a U.S.-Canadian multicenter study.
22 auth.
N. Bräu,
R. Fox,
P. Xiao,
K. Marks,
Z. Naqvi,
L. Taylor,
A. Trikha,
M. Sherman,
M. Sulkowski,
D. Dieterich,
...
M. Rigsby,
T. Wright,
Maria D Hernandez,
M. Jain,
G. Khatri,
R. Sterling,
M. Bonacini,
Catherine A Martyn,
A. Aytaman,
J. Llovet,
Sheldon T. Brown,
E. Bini
|
7 |
2007 |
7
🦁
|
|
🐬
|
Zidovudine use but not weight‐based ribavirin dosing impacts anaemia during HCV treatment in HIV‐infected persons
D. Alvarez,
D. Dieterich,
N. Bräu,
L. Moorehead,
L. Ball,
M. Sulkowski
|
7 |
2006 |
7
🐬
|
|
🐜
|
Daclatasvir for previously untreated chronic hepatitis C genotype-1 infection: a randomised, parallel-group, double-blind, placebo-controlled, dose-finding, phase 2a trial.
22 auth.
S. Pol,
R. Ghalib,
V. Rustgi,
C. Martorell,
G. Everson,
H. Tatum,
C. Hézode,
Joseph K. Lim,
J. Bronowicki,
G. Abrams,
...
N. Bräu,
D. W. Morris,
P. Thuluvath,
R. Reindollar,
P. Yin,
U. Diva,
R. Hindes,
F. Mcphee,
D. Hernandez,
M. Wind-Rotolo,
E. Hughes,
S. Schnittman
|
7 |
2012 |
7
🐜
|
|
🐜
|
Prospective Multicenter Study of Eligibility for Antiviral Therapy Among 4,084 U.S. Veterans with Chronic Hepatitis C Virus Infection
27 auth.
E. Bini,
N. Bräu,
S. Currie,
Hui Shen,
B. Anand,
K. Hu,
L. Jeffers,
S. Ho,
David A. Johnson,
W. Schmidt,
P. King,
R. Cheung,
T. Morgan,
J. Awad,
M. Pedrosa,
...
Kyong‐Mi Chang,
A. Aytaman,
F. Simon,
C. Hagedorn,
R. Moseley,
J. Ahmad,
C. Mendenhall,
B. Waters,
D. Strader,
A. Sasaki,
S. Rossi,
T. Wright
|
7 |
2005 |
7
🐜
|
